R432-101-12. Infection Control

  (1) The facility shall have a written plan to effectively prevent, identify, report, evaluate and control infections.

  (2) The plan shall include a method to collect and monitor data and carry out necessary follow-up actions.

  (3) Infection control actions shall be documented consistent with the requirements of the plan and in accordance with Department requirements and standards of medical practice.

  (4) In-service education and training of employees shall be provided to all service and program components of the hospital.

  (5) The infection control plan shall be reviewed and revised as necessary, but at least annually.

  (6) The hospital shall implement an employee health surveillance program and infection control policy which meets the requirements of R432-100-10 and the following:

  (a) complete at the time a person is hired, an employee health inventory that includes the following:

  (i) conditions that may predispose the employee to acquiring or transmitting infectious diseases;

  (ii) conditions that may prevent the employee from satisfactorily performing assigned duties.

  (b) develop employee health screening and immunization components of personnel health programs in accordance with Rule R386-702, concerning communicable diseases;

  (c) employee skin testing by the Mantoux Method or other FDA approved in-vitro serologic test and follow up for tuberculosis shall be done in accordance with R388-804, Special Measures for the Control of Tuberculosis.

  (i) The licensee shall ensure that all employees are skin tested for tuberculosis within two weeks of:

  (A) initial hiring;

  (B) suspected exposure to a person with active tuberculosis; and

  (C) development of symptoms of tuberculosis.

  (ii) all employees with known positive reaction to skin tests are exempt from skin testing.

  (d) report all infections and communicable diseases reportable by law to the local health department in accordance with Section R386-702-3, concerning reportable diseases; and

  (e) comply with the Occupational Safety and Health Administration's Bloodborne Pathogen Standard.